The US saw a slight year-on-year (YoY) improvement in terms of venture capital (VC) funding deals value during the first three quarters (Q1-Q3) of 2024 despite a decline in deal volume. A total of 3,529 VC deals of worth $91.7 billion were announced during the period. This represents a YoY growth of 0.9% in funding value even as VC deal volume fell by 35.1%, according to GlobalData, a leading data and analytics company.
An analysis of GlobalData’s Deals Database revealed that the US saw the announcement of 5,520 VC deals of worth $90.9 billion during Q1-Q3 2023.
Aurojyoti Bose, Lead Analyst at GlobalData, comments: “Economic uncertainties, geopolitical tensions, and the ongoing conflicts have affected the US VC deal landscape in terms of deal volume. However, this did not impact the US’ dominance in global VC funding landscape. as it continues to maintain a significant lead in VC funding activity by deal volume as well as value to other countries but the lead is now much more pronounced in terms of funding value. The US accounted for more than half of the VC funding amount raised globally during Q1-Q3 2024.”
The US accounted for 28.9% share of the total number of VC deals announced globally during Q1-Q3 2024 while its share of the corresponding funding value stood much higher at 50.1%.
It is also noteworthy that the US witnessed announcements of 209 VC deals valued more than or equal to $100 million during Q1-Q3 2024 whereas the number of such deals during Q1-Q3 2023 stood at 162.
Some of the notable VC funding deals announced in the US during Q1-Q3 2024 include: $6 billion raised by X.AI, $1.5 billion by Anduril Industries, $1.1 billion by CoreWeave, $1 billion by Scale AI, $1 billion by Wiz, $1 billion by Xaira Therapeutics and $1 billion worth funding raised by Safe Superintelligence.
